{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Ren's oligopeptide", "SARS-CoV-2", "antiviral drugs", "influenza virus", "virus replication"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36819119", "DateRevised": {"Year": "2023", "Month": "02", "Day": "24"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "02", "Day": "02"}], "Language": ["eng"], "ELocationID": ["1090372", "10.3389/fvets.2022.1090372"], "Journal": {"ISSN": "2297-1769", "JournalIssue": {"Volume": "9", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in veterinary science", "ISOAbbreviation": "Front Vet Sci"}, "ArticleTitle": "Plant-derived Ren's oligopeptide has antiviral effects on influenza virus and SARS-CoV-2.", "Pagination": {"StartPage": "1090372", "MedlinePgn": "1090372"}, "Abstract": {"AbstractText": ["Influenza virus and SARS-CoV-2 virus are two important viruses that cause respiratory tract diseases. The high-frequency mutation of the two types of viruses leads to failure of the durable immune protection of vaccines, meanwhile it also poses continuous challenges to the development of antiviral drugs. Traditional Chinese medicine contains large number of biologically active compounds, and some of them contain broad-spectrum antiviral ingredients. In this study, we extracted antiviral active ingredients from medicinal and edible plants by biotransformation and enzymatic hydrolysis as a drug, and we named this drug Ren's oligopeptide. Further, we analyzed the antiviral activity of this drug and found that Ren's oligopeptide could inhibit the replication of influenza virus and SARS-CoV-2 virus with high anti-virus activities. <i>In vitro</i> experiments showed that the antiviral activity of the Ren's oligopeptide mainly targets the replication process after virus enters the cell. Therefore, Ren's oligopeptide is a promising drug against influenza and COVID-19."], "CopyrightInformation": "Copyright \u00a9 2023 Yu, Huang, Ren and Sun."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China."}], "LastName": "Yu", "ForeName": "Chengzhi", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China."}], "LastName": "Huang", "ForeName": "Yayu", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Wuhan Shiji Maide Biotechnology Company, Wuhan, China."}], "LastName": "Ren", "ForeName": "Xin", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan, China."}], "LastName": "Sun", "ForeName": "Leqiang", "Initials": "L"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Vet Sci", "NlmUniqueID": "101666658", "ISSNLinking": "2297-1769"}, "CoiStatement": "XR was employed by Wuhan Shiji Maide Biotechnology Company. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Gaitonde DY, Moore FC, Morgan MK. Influenza: diagnosis and treatment. Am Fam Physician. (2019) 100:751\u20138.", "ArticleIdList": ["31845781"]}, {"Citation": "Kim H, Webster RG, Webby RJ. Influenza virus: dealing with a drifting and shifting pathogen. Viral Immunol. (2018) 31:174\u201383. 10.1089/vim.2017.0141", "ArticleIdList": ["10.1089/vim.2017.0141", "29373086"]}, {"Citation": "Wester A, Shetty AK. Peramivir injection in the treatment of acute influenza: a review of the literature. Infect Drug Resist. (2016) 9:201\u201314. 10.2147/IDR.S86460", "ArticleIdList": ["10.2147/IDR.S86460", "PMC5001662", "27578993"]}, {"Citation": "Javanian M, Barary M, Ghebrehewet S, Koppolu V, Vasigala V, Ebrahimpour S, et al. . brief review of influenza virus infection. J Med Virol. (2021) 93:4638\u201346. 10.1002/jmv.26990", "ArticleIdList": ["10.1002/jmv.26990", "33792930"]}, {"Citation": "Nov\u00e1kov\u00e1 L, Havl\u00ed\u010dkov\u00e1 M. Monitoring influenza virus oseltamivir resistance - our experience to date. Epidemiol Mikrobiol Imunol Cas Spol pro Epidemiol a Mikrobiol Ces Lek Spol JE Purkyne. (2021) 70:241\u20136.", "ArticleIdList": ["35073702"]}, {"Citation": "Liu J-W, Lin S-H, Wang L-C, Chiu H-Y, Lee J-A. Comparison of antiviral agents for seasonal influenza outcomes in healthy adults and children: a systematic review and network meta-analysis. JAMA Netw Open. (2021) 4:e2119151. 10.1001/jamanetworkopen.2021.19151", "ArticleIdList": ["10.1001/jamanetworkopen.2021.19151", "PMC8363918", "34387680"]}, {"Citation": "Zheng L, Han Y, Guan Y, Zhang X, Song C, Yang J. Risks in clinical applications of oseltamivir phosphate in the real world. Pharmazie. (2020) 75:284\u20137. 10.1691/ph.2020.0352", "ArticleIdList": ["10.1691/ph.2020.0352", "32539927"]}, {"Citation": "Ison MG. Antivirals and resistance: influenza virus. Curr Opin Virol. (2011) 1:563\u201373. 10.1016/j.coviro.2011.09.002", "ArticleIdList": ["10.1016/j.coviro.2011.09.002", "22440914"]}, {"Citation": "Canini L, Conway JM, Perelson AS, Carrat F. Impact of different oseltamivir regimens on treating influenza a virus infection and resistance emergence: insights from a modelling study. PLoS Comput Biol. (2014) 10:e1003568. 10.1371/journal.pcbi.1003568", "ArticleIdList": ["10.1371/journal.pcbi.1003568", "PMC3990489", "24743564"]}, {"Citation": "Hadj Hassine I. Covid-19 vaccines and variants of concern: a review. Rev Med Virol. (2022) 32:e2313. 10.1002/rmv.2313", "ArticleIdList": ["10.1002/rmv.2313", "PMC8646685", "34755408"]}, {"Citation": "Imran M, Kumar Arora M, Asdaq SMB, Khan SA, Alaqel SI, Alshammari MK, et al. . Discovery, development, and patent trends on molnupiravir: a prospective oral treatment for COVID-19. Molecules. (2021) 26:5795. 10.3390/molecules26195795", "ArticleIdList": ["10.3390/molecules26195795", "PMC8510125", "34641339"]}, {"Citation": "Qomara WF, Primanissa DN, Amalia SH, Purwadi FV, Zakiyah N. Effectiveness of remdesivir, lopinavir/ritonavir, and favipiravir for COVID-19 treatment: a systematic review. Int J Gen Med. (2021) 14:8557\u201371. 10.2147/IJGM.S332458", "ArticleIdList": ["10.2147/IJGM.S332458", "PMC8627269", "34849001"]}, {"Citation": "Lamb YN. Nirmatrelvir plus ritonavir: first approval. Drugs. (2022) 82:585\u201391. 10.1007/s40265-022-01692-5", "ArticleIdList": ["10.1007/s40265-022-01692-5", "PMC8933659", "35305258"]}, {"Citation": "Ghasemnejad-Berenji M, Pashapour S. Favipiravir and COVID-19: a simplified summary. Drug Res. (2021) 71:166\u201370. 10.1055/a-1296-7935", "ArticleIdList": ["10.1055/a-1296-7935", "PMC8043595", "33176367"]}, {"Citation": "Frediansyah A, Nainu F, Dhama K, Mudatsir M, Harapan H. Remdesivir and its antiviral activity against COVID-19: a systematic review. Clin Epidemiol Glob Heal. (2021) 9:123\u20137. 10.1016/j.cegh.2020.07.011", "ArticleIdList": ["10.1016/j.cegh.2020.07.011", "PMC7410793", "32838064"]}, {"Citation": "Uzunova K, Filipova E, Pavlova V, Vekov T. Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2. Biomed Pharmacother. (2020) 131:110668. 10.1016/j.biopha.2020.110668", "ArticleIdList": ["10.1016/j.biopha.2020.110668", "PMC7444940", "32861965"]}, {"Citation": "Lee C-C, Hsieh C-C, Ko W-C. Molnupiravir-a novel oral anti-SARS-CoV-2 agent. Antibiot. (2021) 10:1294. 10.3390/antibiotics10111294", "ArticleIdList": ["10.3390/antibiotics10111294", "PMC8614993", "34827232"]}, {"Citation": "Saied AA, Dhawan M, Priyanka, Choudhary OP. SARS-CoV-2 and influenza a virus: dual diagnostics and vaccines. Int. J. Surg. (2022). 102:106653. 10.1016/j.ijsu.2022.106653", "ArticleIdList": ["10.1016/j.ijsu.2022.106653", "PMC9093053", "35568309"]}, {"Citation": "Li T, Peng T. Traditional Chinese herbal medicine as a source of molecules with antiviral activity. Antiviral Res. (2013) 97:1\u20139. 10.1016/j.antiviral.2012.10.006", "ArticleIdList": ["10.1016/j.antiviral.2012.10.006", "PMC7114103", "23153834"]}, {"Citation": "Qurat-ul-ain S, Wang W, Yang M, Du N, Wan S, Zhang L, et al. . Anomeric selectivity and influenza a virus inhibition study on methoxylated analogues of Pentagalloylglucose. Carbohydr Res. (2015) 402:152\u20137. 10.1016/j.carres.2014.10.011", "ArticleIdList": ["10.1016/j.carres.2014.10.011", "25498015"]}, {"Citation": "Li R, Liu T, Liu M, Chen F, Liu S, Yang J. Anti-influenza a virus activity of dendrobine and its mechanism of action. J Agric Food Chem. (2017) 65:3665\u201374. 10.1021/acs.jafc.7b00276", "ArticleIdList": ["10.1021/acs.jafc.7b00276", "28417634"]}, {"Citation": "Saied AA, Metwally AA, Madkhali NAB, Haque S, Dhama K. Egypt's COVID-19 recent happenings and perspectives: a mini-review. Front public Heal. (2021) 9:696082. 10.3389/fpubh.2021.696082", "ArticleIdList": ["10.3389/fpubh.2021.696082", "PMC8415352", "34485226"]}, {"Citation": "Ma H-D, Deng Y-R, Tian Z, Lian Z-X. Traditional Chinese medicine and immune regulation. Clin Rev Allergy Immunol. (2013) 44:229\u201341. 10.1007/s12016-012-8332-0", "ArticleIdList": ["10.1007/s12016-012-8332-0", "22826112"]}, {"Citation": "Olazar\u00e1n-Santiba\u00f1ez F, Rivera G, Vanoye-Eligio V, Mora-Olivo A, Aguirre-Guzm\u00e1n G, Ram\u00edrez-Cabrera M, et al. . Antioxidant and antiproliferative activity of the ethanolic extract of equisetum myriochaetum and molecular docking of its main metabolites (Apigenin, Kaempferol, and Quercetin) on \u03b2-Tubulin. Molecules. (2021) 26:443. 10.3390/molecules26020443", "ArticleIdList": ["10.3390/molecules26020443", "PMC7831036", "33466999"]}, {"Citation": "Ankri S, Mirelman D. Antimicrobial properties of allicin from garlic. Microbes Infect. (1999) 1:125\u20139. 10.1016/S1286-4579(99)80003-3", "ArticleIdList": ["10.1016/S1286-4579(99)80003-3", "10594976"]}, {"Citation": "Chapman RL, Andurkar SV. A review of natural products, their effects on SARS-CoV-2 and their utility as lead compounds in the discovery of drugs for the treatment of COVID-19. Med Chem Res Int J Rapid Commun Des Mech Action Biol Act Agents. (2022) 31:40\u201351. 10.1007/s00044-021-02826-2", "ArticleIdList": ["10.1007/s00044-021-02826-2", "PMC8636070", "34873386"]}, {"Citation": "Richard SA. Exploring the pivotal immunomodulatory and anti-inflammatory potentials of glycyrrhizic and glycyrrhetinic acids. Mediators Inflamm. (2021) 2021:6699560. 10.1155/2021/6699560", "ArticleIdList": ["10.1155/2021/6699560", "PMC7808814", "33505216"]}, {"Citation": "Remali J, Aizat WM. A review on plant bioactive compounds and their modes of action against coronavirus infection. Front Pharmacol. (2020) 11:589044. 10.3389/fphar.2020.589044", "ArticleIdList": ["10.3389/fphar.2020.589044", "PMC7845143", "33519449"]}, {"Citation": "Rouf R, Uddin SJ, Sarker DK, Islam MT, Ali ES, Shilpi JA, et al. . Antiviral potential of garlic (Allium sativum) and its organosulfur compounds: a systematic update of pre-clinical and clinical data. Trends food Sci Technol. (2020) 104:219\u201334. 10.1016/j.tifs.2020.08.006", "ArticleIdList": ["10.1016/j.tifs.2020.08.006", "PMC7434784", "32836826"]}, {"Citation": "G\u00f6kalp F. The inhibition effect of garlic-derived compounds on human immunodeficiency virus type 1 and saquinavir. J Biochem Mol Toxicol. (2018) 32:e22215. 10.1002/jbt.22215", "ArticleIdList": ["10.1002/jbt.22215", "30194790"]}, {"Citation": "Hall A, Troupin A, Londono-Renteria B, Colpitts TM. Garlic organosulfur compounds reduce inflammation and oxidative stress during dengue virus infection. Viruses. (2017) 9:157. 10.3390/v9060159", "ArticleIdList": ["10.3390/v9060159", "PMC5537651", "28644404"]}, {"Citation": "Almehmady AM, Ali SA. Transdermal film loaded with garlic oil-acyclovir nanoemulsion to overcome barriers for its use in alleviating cold sore conditions. Pharmaceutics. (2021) 13:669. 10.3390/pharmaceutics13050669", "ArticleIdList": ["10.3390/pharmaceutics13050669", "PMC8148569", "34066923"]}, {"Citation": "Rasool A, Khan M-U-R, Ali MA, Anjum AA, Ahmed I, Aslam A, et al. . Anti-avian influenza virus H9N2 activity of aqueous extracts of Zingiber officinalis (Ginger) and Allium sativum (Garlic) in chick embryos. Pak J Pharm Sci. (2017) 30:1341\u20134.", "ArticleIdList": ["29039335"]}, {"Citation": "Khubber S, Hashemifesharaki R, Mohammadi M, Gharibzahedi SMT. Garlic (Allium sativum L.): a potential unique therapeutic food rich in organosulfur and flavonoid compounds to fight with COVID-19. Nutr J. (2020) 124:1\u20133. 10.1186/s12937-020-00643-8", "ArticleIdList": ["10.1186/s12937-020-00643-8", "PMC7673072", "33208167"]}, {"Citation": "Dorrigiv M, Zareiyan A, Hosseinzadeh H. Onion (Allium cepa) and its main constituents as antidotes or protective agents against natural or chemical toxicities: a comprehensive review. Iran J Pharm Res IJPR. (2021) 20:3\u201326. 10.22037/ijpr.2020.112773.13940", "ArticleIdList": ["10.22037/ijpr.2020.112773.13940", "PMC8170763", "34400937"]}, {"Citation": "Lebdah M, Tantawy L, Elgamal AM, Abdelaziz AM, Yehia N, Alyamani AA, et al. . The natural antiviral and immune stimulant effects of Allium cepa essential oil onion extract against virulent Newcastle disease virus. Saudi J Biol Sci. (2022) 29:1239\u201345. 10.1016/j.sjbs.2021.09.033", "ArticleIdList": ["10.1016/j.sjbs.2021.09.033", "PMC8847923", "35197791"]}, {"Citation": "Semwal RB, Semwal DK, Combrinck S, Viljoen AM. Gingerols and shogaols: important nutraceutical principles from ginger. Phytochemistry. (2015) 117:554\u201368. 10.1016/j.phytochem.2015.07.012", "ArticleIdList": ["10.1016/j.phytochem.2015.07.012", "26228533"]}, {"Citation": "Wang J, Prinz RA, Liu X, Xu X. In vitro and in vivo antiviral activity of gingerenone a on influenza a virus is mediated by targeting janus kinase 2. Viruses. (2020) 12:1141. 10.3390/v12101141", "ArticleIdList": ["10.3390/v12101141", "PMC7650803", "33050000"]}, {"Citation": "Puri M, Kaur I, Kanwar RK, Gupta RC, Chauhan A, Kanwar JR. Ribosome inactivating proteins (RIPs) from Momordica charantia for anti viral therapy. Curr Mol Med. (2009) 9:1080\u201394. 10.2174/156652409789839071", "ArticleIdList": ["10.2174/156652409789839071", "19747115"]}, {"Citation": "Pongthanapisith V, Ikuta K, Puthavathana P, Leelamanit W. Antiviral protein of Momordica charantia L. inhibits different subtypes of influenza a evid based complement. Alternat Med. (2013) 2013:729081. 10.1155/2013/729081", "ArticleIdList": ["10.1155/2013/729081", "PMC3722788", "23935676"]}, {"Citation": "Cho S-J, Rhee D-K, Pyo S. Allicin, a major component of garlic, inhibits apoptosis of macrophage in a depleted nutritional state. Nutrition. (2006) 22:1177\u201384. 10.1016/j.nut.2006.08.011", "ArticleIdList": ["10.1016/j.nut.2006.08.011", "17027231"]}, {"Citation": "Gautam SC, Gao X, Dulchavsky S. Immunomodulation by curcumin. Adv Exp Med Biol. (2007) 595:321\u201341. 10.1007/978-0-387-46401-5_14", "ArticleIdList": ["10.1007/978-0-387-46401-5_14", "17569218"]}, {"Citation": "Phuaklee P, Ruangnoo S, Itharat A. Anti-inflammatory and antioxidant activities of extracts from Musa sapientum peel. J Med Assoc Thai. (2012) 95:S142\u20136.", "ArticleIdList": ["23964457"]}, {"Citation": "Thota SM, Balan V, Sivaramakrishnan V. Natural products as home-based prophylactic and symptom management agents in the setting of COVID-19. Phytother Res. (2020) 34:3148\u201367. 10.1002/ptr.6794", "ArticleIdList": ["10.1002/ptr.6794", "PMC7461159", "32881214"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "11", "Day": "5"}, {"Year": "2022", "Month": "12", "Day": "28"}, {"Year": "2023", "Month": "2", "Day": "23", "Hour": "10", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "24", "Hour": "6", "Minute": "1"}, {"Year": "2023", "Month": "2", "Day": "2"}], "PublicationStatus": "epublish", "ArticleIdList": ["36819119", "PMC9932202", "10.3389/fvets.2022.1090372"]}}], "PubmedBookArticle": []}